| Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| CHRNB4 |
cholinergic receptor, nicotinic beta 4 |
15q24 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
IBA
|
| CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
15q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IDA[8145738|12189247]
|
| CHRNA2 |
cholinergic receptor, nicotinic alpha 2 |
8p21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IBA
|
| CHRNA4 |
cholinergic receptor, nicotinic alpha 4 |
20q13.33 |
Literature-origin |
1(1/0/0)
|
IDA[12189247]
|
| CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IEA
|
| DRD2 |
dopamine receptor D2 |
11q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
18(11/7/0)
|
IEA
|
| SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(11/10/0)
|
IEA
|
| CHRNA6 |
cholinergic receptor, nicotinic alpha 6 |
8p22 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
IBA
|
| CHRNB3 |
cholinergic receptor, nicotinic beta 3 |
8p11.21 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IBA
|
| NOS1 |
nitric oxide synthase 1 |
12q24.22 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IEA
|
| PENK |
proenkephalin |
8q12.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(1/1/0)
|
IEA
|
Basic Info
